AngioDynamics Income Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Revenue	320.17	292.5	303.91	338.75	316.22
Revenue Growth (YoY)	9.46%	-3.76%	-10.28%	7.13%	8.66%
Cost of Revenue	145.28	134.79	149.22	164.51	150.49
Gross Profit	174.89	157.71	154.7	174.25	165.73
Selling, General & Admin	157.09	145.23	143.98	144.25	133.75
Depreciation & Amortization Expenses	10.68	10.32	13.05	18.79	19.46
Research & Development	29.45	26.22	31.51	29.88	30.74
Other Operating Expenses	17.6	15.89	158.59	32.5	10.25
Total Operating Expenses	214.82	197.66	347.13	225.43	194.2
Operating Income	-39.93	-39.95	-192.44	-51.18	-28.47
Total Non-Operating Income (Expense)	3.63	5.92	0.8	-3.26	-1.48
Pretax Income	-36.3	-34.03	-191.64	-54.44	-29.95
Provision for Income Taxes	0.44	-0.04	-7.29	-2	-3.4
Net Income	-36.74	-33.99	-184.35	-52.44	-26.55
Net Income to Common	-36.74	-33.99	-184.35	-52.44	-26.55
Shares Outstanding (Basic)	42	41	40	39	39
Shares Outstanding (Diluted)	42	41	40	39	39
Shares Change (YoY)	1.65%	1.67%	1.77%	1.21%	1.74%
EPS (Basic)	-0.88	-0.83	-4.59	-1.33	-0.68
EPS (Diluted)	-0.88	-0.83	-4.59	-1.33	-0.68
Free Cash Flow	-2.86	-20.31	-35.69	-9.13	-22.9
Free Cash Flow Per Share	-0.07	-0.50	-0.89	-0.23	-0.59
Gross Margin	54.62%	53.92%	50.90%	51.44%	52.41%
Operating Margin	-12.47%	-13.66%	-63.32%	-15.11%	-9.00%
Profit Margin	-11.48%	-11.62%	-60.66%	-15.48%	-8.40%
FCF Margin	-0.89%	-6.94%	-11.74%	-2.69%	-7.24%
EBITDA	-16.97	-14.15	-164.72	-20.31	0.88
EBITDA Margin	-5.30%	-4.84%	-54.20%	-5.99%	0.28%
EBIT	-39.93	-39.95	-192.44	-51.18	-28.47
EBIT Margin	-12.47%	-13.66%	-63.32%	-15.11%	-9.00%
Effective Tax Rate	-1.22%	0.11%	3.80%	3.66%	11.36%

SEC Filings: 10-K · 10-Q